Literature DB >> 448396

Nasal encephalocoele. Treatment by trans-cranial operation.

N U Rahman.   

Abstract

Results are described of 86 intracranial operations for the repair of nasal encephalocoele children at the Lahore Neurosurgical Centre in the last 13 years. These midline lesions at the base of the anterior cranial fossa have been considered in the past to be inoperable and even when operable, unpleasantly difficult. The intracranial approach has made it possible to treat this condition satisfactorily with comparatively few complications. Attempts at extra-cranial repair have met little success as they do not take into account the basic embryology and anatomy of the condition and fail to tackle the sac at the patent foramen caecum, the neck of the sac. This paper describes the embryology, anatomy, basic pathology and clinical features of the condition with characteristic X-rays showing the patent foramen caecum and outlines the operative repair.

Entities:  

Mesh:

Year:  1979        PMID: 448396     DOI: 10.1016/0022-510x(79)90153-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Management of anterior encephalocele.

Authors:  A D Hockley; J H Goldin; M J Wake
Journal:  Childs Nerv Syst       Date:  1990-12       Impact factor: 1.475

2.  Nasal encephalocoele -an atypical case.

Authors:  N Chaudhary; Nimesh Gupta; S Gudwani; A Safaya
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2004-01

3.  Cephaloceles: classification, pathology, and management.

Authors:  D J David; T W Proudman
Journal:  World J Surg       Date:  1989 Jul-Aug       Impact factor: 3.352

4.  Intranasal (transethmoidal) encephalomeningocele. Case report.

Authors:  Z Sekerci; O Iyigün; S Bariş; C Cokluk; G Bozkurt; C Rakunt; F Celik
Journal:  Neurosurg Rev       Date:  1995       Impact factor: 3.042

5.  New perspectives in the management of severe cranio-facial deformity.

Authors:  D J David
Journal:  Ann R Coll Surg Engl       Date:  1984-07       Impact factor: 1.891

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.